首页> 外文期刊>Molecular pharmaceutics >Cyclosporin A-loaded poly(ethylene glycol)-b-poly(d,l-lactic acid) micelles: preparation, in vitro and in vivo characterization and transport mechanism across the intestinal barrier.
【24h】

Cyclosporin A-loaded poly(ethylene glycol)-b-poly(d,l-lactic acid) micelles: preparation, in vitro and in vivo characterization and transport mechanism across the intestinal barrier.

机译:载有环孢菌素A的聚(乙二醇)-b-聚(d,l-乳酸)胶束:制备,体外和体内表征以及跨肠屏障的转运机制。

获取原文
获取原文并翻译 | 示例
       

摘要

To improve the oral bioavailability of poorly water-soluble cyclosporin A (CyA), polymeric micelles based on monomethoxy poly(ethylene glycol)-b-poly(d,l-lactic acid) (mPEG-PLA) were prepared. In vitro release test showed that the cumulative release percentage, about 85%, of CyA from polymeric micelles within 24 h was comparable to that from Sandimmun Neoral, the currently available oral formulation of CyA. A relative oral bioavailability of 137% in rats compared with Sandimmun Neoral was demonstrated for CyA-loaded polymeric micelles. The other aim of the current work was to study the transport mechanism of mPEG-PLA micelles across the intestinal barrier. It was found that polymeric micelles could significantly increase the permeability of CyA across Caco-2 monolayers without significantly affecting transepithelial electrical resistance values, and the apparent permeation coefficient (P(app)) of CyA was significantly higher in the AP-BL direction compared to that in the BL-AP direction, suggesting that polymeric micelles might undergo an active AP to BL transport that probably involved endocytosis which was confirmed by confocal microscope observation. The permeation of CyA through Caco-2 monolayers showed that the P(app) was significantly increased when CyA was formulated with the copolymer below its critical association concentration (CAC) and no significant difference was found above its CAC, implying that mPEG-PLA monomers affected the intestinal P-gp efflux pumps. Therefore, the mPEG-PLA micelles seemed to be a good candidate for oral delivery of poorly soluble drugs.
机译:为了提高水溶性差的环孢菌素A(CyA)的口服生物利用度,制备了基于单甲氧基聚(乙二醇)-b-聚(d,l-乳酸)(mPEG-PLA)的聚合物胶束。体外释放试验表明,在24小时内,聚合胶束中CyA的累积释放百分比约为85%,与目前可用的CyA口服制剂Sandimmun Neoral的释放百分比相当。与Sandimmun Neoral相比,在大鼠体内相对口服生物利用度为137%,这是CyA加载的聚合物胶束的结果。当前工作的另一个目的是研究mPEG-PLA胶束穿过肠道屏障的转运机制。发现聚合物胶束可以显着增加CyA在Caco-2单层上的渗透性,而不会显着影响跨上皮电阻值,并且与AP-BL方向相比,CyA的表观渗透系数(P(app))明显更高。在共聚焦显微镜观察中证实,这表明聚合物胶束可能会经历活性AP到BL的转运,可能涉及内吞作用。 CyA通过Caco-2单层的渗透表明,当CyA配制成低于其临界缔合浓度(CAC)的共聚物时,P(app)显着增加,并且在其CAC之上未发现显着差异,这暗示mPEG-PLA单体影响了肠道P-gp外排泵。因此,mPEG-PLA胶束似乎是难溶性药物口服给药的良好候选者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号